Connect with us

Business

How two companies sprinted ahead in the extraordinary race for a COVID vaccine – Sydney Morning Herald

Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer chief Albert Bourla called on his top vaccine scientists and laid…

Published

on

What followed was a full-bore effort carried out under strict coronavirus lockdown conditions, . On November 9, Pfizer and its German partner BioNTech SE reported the first promising results from large-scale, scientifically rigorous clinical trials around the world followed by US biotech Moderna announcing its own successful trial – although potential roadblocks remain and widespread distribution is not expected until at least April.
Both companies have reported preliminary findings of more than…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending